Crimean-Congo Hemorrhagic Fever

Ron Smith, MD

Crimean-Congo Hemorrhagic Fever (CCHF) in the News

This transmission electron microscopic (TEM) image revealed the presence of numerous Ganjam virus virions in this tissue specimen. This Nairoviridae family member is antigenically, closely related to, and an Asian variant of, the Nairobi sheep disease virus (NSDV). Though not contagious, Ganjam virus is an arbovirus, spread through the bite of certain ticks, including Haemaphysalis intermedia, and Rhipicephalus hemaphysaloides. Ganjam virus is a negative-sense single-stranded RNA viruses ((-) ssRNA), which are spread through contact with infected arthropods and rodents.


Monday, 1 May 2023

Senegal Health Ministry Confirms Crimean-Congo Hemorrhagic Fever Case in Dakar

The case of Crimean-Congo hemorrhagic fever was detected on April 21 in the Dalal Jamm hospital in Guediawaye, the health ministry said in a statement late Saturday, US News reported. A health emergency task force has been assigned to oversee the incident. According to the World Health Organization (WHO), the tick-borne CCHF virus can spread between people through close contact with blood or body fluids. The death rate ranges from 10% to 40%.



Sunday, 24 July 2022

Deadly Crimean Congo tick which kills 30 % of people it infects has hospitalised a man in Spain

Third case report since April.


Quick Overview

Crimean-Congo Hemorrhagic Fever

 

Crimean-Congo hemorrhagic fever (CCHF) is caused by infection with a tick-borne virus (Nairovirus) in the family Bunyaviridae. The disease was first characterized in the Crimea in 1944 and given the name Crimean hemorrhagic fever. It was then later recognized in 1969 as the cause of illness in the Congo, thus resulting in the current name of the disease.

Crimean-Congo hemorrhagic fever is found in Eastern Europe, particularly in the former Soviet Union, throughout the Mediterranean, in northwestern China, central Asia, southern Europe, Africa, the Middle East, and the Indian subcontinent.

Transmission

Ixodid (hard) ticks, especially those of the genus, Hyalomma, are both a reservoir and a vector for the CCHF virus. Numerous wild and domestic animals, such as cattle, goats, sheep and hares, serve as amplifying hosts for the virus. Transmission to humans occurs through contact with infected ticks or animal blood. CCHF can be transmitted from one infected human to another by contact with infectious blood or body fluids. Documented spread of CCHF has also occurred in hospitals due to improper sterilization of medical equipment, reuse of injection needles, and contamination of medical supplies.

Signs and Symptoms

The onset of CCHF is sudden, with initial signs and symptoms including headache, high fever, back pain, joint pain, stomach pain, and vomiting. Red eyes, a flushed face, a red throat, and petechiae (red spots) on the palate are common. Symptoms may also include jaundice, and in severe cases, changes in mood and sensory perception.

As the illness progresses, large areas of severe bruising, severe nosebleeds, and uncontrolled bleeding at injection sites can be seen, beginning on about the fourth day of illness and lasting for about two weeks. In documented outbreaks of CCHF, fatality rates in hospitalized patients have ranged from 9% to as high as 50%.

The long-term effects of CCHF infection have not been studied well enough in survivors to determine whether or not specific complications exist. However, recovery is slow.

Risk of Exposure

Animal herders, livestock workers, and slaughterhouse workers in endemic areas are at risk of CCHF. Healthcare workers in endemic areas are at risk of infection through unprotected contact with infectious blood and body fluids. Individuals and international travelers with contact to livestock in endemic regions may also be exposed.

Diagnosis

Laboratory tests that are used to diagnose CCHF include antigen-capture enzyme-linked immunosorbent assay (ELISA), real time polymerase chain reaction (RT-PCR), virus isolation attempts, and detection of antibody by ELISA (IgG and IgM). Laboratory diagnosis of a patient with a clinical history compatible with CCHF can be made during the acute phase of the disease by using the combination of detection of the viral antigen (ELISA antigen capture), viral RNA sequence (RT-PCR) in the blood or in tissues collected from a fatal case and virus isolation. Immunohistochemical staining can also show evidence of viral antigen in formalin-fixed tissues. Later in the course of the disease, in people surviving, antibodies can be found in the blood. But antigen, viral RNA and virus are no more present and detectable.

Treatment

Treatment for CCHF is primarily supportive. Care should include careful attention to fluid balance and correction of electrolyte abnormalities, oxygenation and hemodynamic support, and appropriate treatment of secondary infections. The virus is sensitive in vitro to the antiviral drug ribavirin. It has been used in the treatment of CCHF patients reportedly with some benefit.

Recovery

The long-term effects of CCHF infection have not been studied well enough in survivors to determine whether or not specific complications exist. However, recovery is slow.

Prevention

Agricultural workers and others working with animals should use insect repellent on exposed skin and clothing. Insect repellants containing DEET (N, N-diethyl-m-toluamide) are the most effective in warding off ticks. Wearing gloves and other protective clothing is recommended. Individuals should also avoid contact with the blood and body fluids of livestock or humans who show symptoms of infection. It is important for healthcare workers to use proper infection control precautions to prevent occupational exposure.

Resources

Khan A, et al. Viral Hemorrhagic Fevers. Seminars in Pediatric Infectious Diseases. Philadelphia: WB Saunders Co., 1997;8 (suppl 1):64-73. Peters CJ. Viral Hemorrhagic Fevers. Viral Pathogenesis. New York: Lippincott-Raven Publishers, 1997:779-794.

Khan AS, et al. Viral Hemorrhagic Fevers and Hantavirus Pulmonary Syndrome. In HF Conn, RH Clohecy, RB Conn, eds. Current Diagnosis 9. Philadelphia: WB Saunders Co., 1997:193-194..


Crimean-Congo Hemorrhagic Fever (CCHF) Distribution Map

Areas endemic for CCHF

  • Albania
  • Armenia
  • Azerbaijan
  • Benin
  • Bosnia and  Hercegovina
  • Bulgaria
  • Burkina Faso
  • Central African Republic
  • China
  • Croatia
  • DR Congo
  • Egypt
  • Ethiopia
  • Georgia
  • Greece
  • Guinea
  • India
  • Iran
  • Iraq
  • Kazakhstan
  • Kenya
  • Kirgizstan
  • Macedonia
  • Madagascar
  • Mali
  • Mauritania
  • Montenegro
  • Namibia
  • Nigeria
  • Oman
  • Pakistan
  • Russia
  • Saudi Arabia
  • Senegal
  • Serbia
  • Slovenia
  • South Africa
  • South Sudan
  • Sudan
  • Tajikistan
  • Tanzania
  • Turkey
  • Turkmenistan
  • UAE
  • Uganda
  • Ukraine
  • Zimbabwe